Department of Cardiac Surgery, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
BMC Pediatr. 2024 Sep 17;24(1):590. doi: 10.1186/s12887-024-05062-w.
This study aims to evaluate the application value in neurological outcome of cerebral regional oxygen saturation (CrSO) and amplitude-integrated electroencephalography (aEEG) monitoring during neonatal extracorporeal membrane oxygenation (ECMO) courses.
We retrospectively analyzed 18 neonates receiving veno-arterial ECMO (V-A ECMO) support at our hospital from July 2021 to December 2022. Continuous monitoring of CrSO and brain electrical activity was conducted using near-infrared spectroscopy (NIRS) and aEEG throughout the ECMO treatment. We collected and analyzed related clinical data.
Among the 11 survivors, 5 were categorized as the normal group (N group) and 6 as the abnormal group (AN group) based on post-ECMO brain MRI outcomes. The N group exhibited shorter time percentage of significant CrSO reduction (> 25% from baseline or absolute value < 40%), better fractional tissue oxygen extraction (FTOE) rates, and more stable mean percentage changes in CrSO compared to the AN group. Neonates in the N group predominantly showed mildly abnormal aEEG readings, with one patient displaying disrupted sleep-wake cycles. This particular patient also had more significant CrSO reduction and poorer FTOE compared to others in the N group. Additionally, the Test of Infant Motor Performance (TIMP) scores indicated hypoevolutism in this patient before discharge, while others in the N group had normal TIMP scores. In the AN group, 4 exhibited moderate and 2 severe aEEG abnormalities; 5 had hypoevolutism TIMP scores, and 1 with moderate aEEG abnormalities maintained a normal TIMP score, exhibiting lesser CrSO reduction and improved FTOE.
CrSO and aEEG monitoring show potential as routine assessments for neurological outcomes during neonatal ECMO. In our cohort, a tendency was observed where neonates with greater reductions in CrSO and more severe aEEG abnormalities experienced poorer neurological outcomes.
本研究旨在评估脑区域性氧饱和度(CrSO)和振幅整合脑电图(aEEG)监测在新生儿体外膜肺氧合(ECMO)过程中的神经功能结局的应用价值。
我们回顾性分析了 2021 年 7 月至 2022 年 12 月在我院接受静脉-动脉 ECMO(V-A ECMO)支持的 18 例新生儿。在整个 ECMO 治疗过程中,使用近红外光谱(NIRS)和 aEEG 对 CrSO 和脑电活动进行连续监测。我们收集并分析了相关的临床数据。
在 11 例幸存者中,根据 ECMO 后脑 MRI 结果,5 例分为正常组(N 组),6 例分为异常组(AN 组)。与 AN 组相比,N 组 CrSO 显著降低(与基线相比下降>25%或绝对值<40%)的时间百分比更短,组织氧提取分数(FTOE)更高,CrSO 的平均百分比变化更稳定。N 组的新生儿主要表现为轻度异常的 aEEG 读数,1 例患者表现为睡眠-觉醒周期中断。与 N 组的其他患者相比,该患者的 CrSO 降低更显著,FTOE 更差。此外,该患者在出院前的婴儿运动表现测试(TIMP)评分显示发育迟缓,而 N 组的其他患者 TIMP 评分正常。在 AN 组中,4 例表现为中度和 2 例重度 aEEG 异常;5 例 TIMP 评分发育迟缓,1 例中度 aEEG 异常患者 TIMP 评分正常,CrSO 降低较少,FTOE 改善。
CrSO 和 aEEG 监测在新生儿 ECMO 期间作为神经功能结局的常规评估具有潜力。在我们的队列中,CrSO 降低更大和 aEEG 异常更严重的新生儿,神经功能结局更差。